Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

17 best payday loans online: Quick cash and fast approval this Christmas

If you face a financial emergency, traditional loans may not be a viable option if you have bad credit. So what can you do when you need quick cash – especially close if you need cash for Christmas gifts during the festive season? The best online payday loans are an a...

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales

Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth. Biopharmaceutical company Puma Biotechnology Inc. (PBYI:NADSAQ) shares opened more than 20% higher to...

Olympia Financial Group: With us, it's personal

Olympia Financial Group conducts most of its operations through Olympia Trust Company, providing trust and custodial services to investors in Canada’s private capital markets. The company serves clients from across Canada and is a significant player i...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

Buzz on the Bullboards: Stocks making headlines

It can be hard to know when to make a move when every day looks crazier than the last. Traders don’t not know what to expect coming in tomorrow’s news cycle … but you can bet the markets are going to be volatile day-to-day. This has bee...

ImmunoGen Shares Rise 25% on FY/19 Financial Results and Clinical Pipeline Updates

Shares of ImmunoGen Inc. reached a new 52-week intraday high price after the company announced FY/19 financial results and reported on recent developments including the completion of a $97.6 million capital raise in January 2020. Clinical-stage biotechnology...

North America's 'Newest Gold Royalty Company' Gaining Recognition

This company's unique option/royalty model has caught the attention of major resource investors. Ely Gold Royalties Inc. (ELY:TSX.V; ELYGF:OTCQB) features a unique royalty generation model. The company holds a sizeable portfolio of resource properties in the Western ...

With $5 Million in New Financing, This Small Cap Oil Company Sees Opportunity in the ...

With $5 Million in New Financing, This Small Cap Oil Company Sees Opportunity in the Midst of a Pandemic-Induced Major Oil Downturn Jericho Oil Corp.'s just-closed $5 million insider financing allows it to capitalize on the distress in the market right now. ...

FedEx Shares Down 13.5% on Earnings and Global Trade Concerns

FedEx Corp. shares are trading much lower today after it reported Q1/20 earnings. The firm confirmed it will raise prices by 4.9% to 5.9% in January 2020. After the close of trading yesterday express air freight carrier FedEx Corp. (FDX:NYSE) announced consolidated...

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. This morning Marinus Pharmaceuticals Inc. (MRNS:NASDAQ) , a pharmaceutical firm dedicated to...
1 2 3 4 5 6 7 8 9 10 ...